Fundamental Analysis of Entera Bio Ltd. WT - Growth / Value Index
ENTXW - Valuation Highlights
Valuation Analysis
Tsr Value Index - Excellent Score of 89.29
Undervalued - Price to Intrinsic Value of 0.0004
Price to Earning Ratio is 1.14 and EV to EBITDA is 0 suggesting company is undervalued.
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 1.14 | 0.0026 | -6.75 % | |
| Price to Book | 1.40 | 0.0029 | 92.01 % | 0.0042 |
| Price to Sales | 129.13 | 0.258 | 326.20 % | |
| Enterprise Value to EBITDA Multiple | 0 | -0.918 | 54.25 % |
ENTXW - Profitability Highlights
Profitability Analysis
Earning Yield of 87.49 %
During the past twelve months, the company has given a strong Return On Equity of 122.79%
During the past twelve months, the company has given a strong Return On Asset of 108.44%
During the past twelve months, the company has given a strong Net Margin of 11297.76%
Piotroski F Score - Stable Value of 4.0
Annual Net Profit in last 3 years is trending up
EBITDA is continuously increasing for last 3 Years
Tsr Profitability Index - Very Poor Score of 8.59
Very Low Dividend Yield of 0 %
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 122.79 | 111.20 | 105.90 % | -28.24 |
| Return On Asset | 108.44 | 99.57 | 112.33 % | -22.26 |
| Net Profit Margin | 11297.76 | 9754.48 | 357.03 % | 0 |
| Operating Profit Margin | -14802.24 | -9752.24 | -355.80 % | 0 |
| EBITDA Margin | 4871.64 | 9904.48 | 359.83 % | 0 |
Highlights
| Market Cap | 0 |
| Enterprise Value | 0 |
| Price/Book TTM | 1.40 |
| Outstanding Share | 0 |
| Float/ Outstanding Share | % |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 0.0122 |
| Peter Lynch Ratio | 6.33 |
| Piotroski F Score | 4.00 |
| Altman Z Score | -5.80 |
| Sloan Ratio | 1.95 |
| Peter Lynch Fair Value | 0.0262 |
ENTXW - Growth Highlights
Growth Analysis
YoY Net Margin Jump by 357.03%
Quarterly sales in last 5 Quarter is trending down
Companies' sales dropped by 76.53 % from last year
Operating Cash Flow decreasing for last 3 year
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 134000 | 76.53 % | % |
| Gross Profit | -2179.00 K | 83.33 % | 100.00 % |
| EBITDA | 6528.00 K | 7.91 % | 47.83 % |
| Net Profit | 15139.00 K | 7.25 % | 152.93 % |
| EPS | 0.0010 | 7.23 % | NA |
ENTXW - Stability Highlights
Stability Analysis
Debt to equity ratio has decreased and is lowest in last three years
Cash ratio of 9.18
Company financial liquidity has improved
Altman Z Score of -5.80 suggest high risk
Company is unable to generate enough free cash to support the business.
Interest Coverage of -0.508
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.0077 | -2.40 % | 0.0058 |
| Cash Ratio | 9.18 | 16.56 % | |
| Quick Ratio | 9.80 | 0 % | 5.61 |
| Shareholders Equity | 89.54 | 3.12 % | |
| Debt to EBITDA | 0.0069 | -52.89 % |
Historical Valuation Ratios of Entera Bio Ltd. WT
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Entera Bio Ltd. WT
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Entera Bio Ltd. WT
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Entera Bio Ltd. WT
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)